An audit of the role of vitamin K in the reversal of international normalised ratio (INR) in patients undergoing surgery for hip fracture

Annals of the Royal College of Surgeons of England

Volumn 92, Issue 6, 2010, Pages 473-476

  Bhatia, Maneesh ^a   Talawadekar, Gautam ^b   Parihar, Sailendra ^b   Smith, Andrew ^b  

^a WILLIAM HARVEY HOSPITAL   (United Kingdom)

^b EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Hip fracture; INR; Vitamin K

Indexed keywords

ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; VITAMIN K GROUP; WARFARIN;

AGED; ARTICLE; BLOOD CLOTTING; CLINICAL TRIAL; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; FEMUR NECK FRACTURE; FRACTURE FIXATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; MEDICAL AUDIT; METHODOLOGY; MULTICENTER STUDY; PRACTICE GUIDELINE; PREOPERATIVE CARE; PREOPERATIVE PERIOD;

AGED; ANTICOAGULANTS; ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION; FEMALE; FEMORAL NECK FRACTURES; FRACTURE FIXATION; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MEDICAL AUDIT; PRACTICE GUIDELINES AS TOPIC; PREOPERATIVE CARE; PREOPERATIVE PERIOD; VITAMIN K; WARFARIN;

EID: 77957906199     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588410X12664192075774     Document Type: Article

References (18)

1. Ibrahim I, Lodhi Y, Charalombous CP, Shahid R, Zubairy AI, Tandon V. A prospective outcome analysis fracture neck of femur. Injury Extra 2007; 38: 143-4.
2. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 1998; 352: 1167-71.
3. Tharmarajah P, Pussey J, Keeling D, Willett K. Efficacy of warfarin reversal inorthopaedic trauma surgery patients. J Orthop Trauma 2007: 21: 26-30.
4. Hanley JP. Warfarin reversal. J Clin Pathol 2004; 57: 1132-9.
5. Salamat A, Seaton J, Watson HG. Impact of introducing guidelines on anticoagulant reversal. Transfus Med 2005; 15: 99-105.
6. Gogna A, Arun S. Oral anticoagulation in clinical practice. J Indian Acad Clin Med 2005; 6: 53-66.
7. Al-Rashid M, Parker MJ. Anticoagulation management in hip fracture patients on warfarin. Injury 2005; 36: 1311-5.
8. British Committee for Standards in Haematology. Guidelines on oral anticoagulation, 3rd edn. Br J Haematol 1998; 101: 374-87.
9. Jaffer AK, Brotman DJ, Chukwumerije N. When patients on warfarin need surgery. Cleveland Clin J Med 2003; 70: 973-84.
10. Hynson J, Katz J, Bueff H. Epidural haematoma associated with enoxaparin. Anesth Analg 1996; 82: 1072-5.
11. Scottish Intercollegiate Guidelines Network (SIGN). Prevention and management of hip fracture in older people; a national clinical guideline. Edinburgh: Royal College of Physicians of Edinburgh, 2002; SIGN publication 56.
12. Shields RC. Efficacy and safety of intravenous phytonadione (vitamin K) in patients on long term oral anticoagulation therapy. Mayo Clin Proc 2001; 76: 260-6.
13. Despotis GJ, Filos KS, Zoys TN, Hogue Jr CW, Spitznagel E, Lappas DG. Factors associated with excessive post-operative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients. Anesth Analg 1996; 82; 13-21.
14. Landefeld S, Cook F, Flately M. Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med 1987; 82: 703-23.
15. Travis S, Wray R, Harrison K. Perioperative anticoagulation control. Br J Surg 1989; 76: 1107-8.
16. Hylek EM, Singer DE. Risk factors for intracranial haemorrhage in outpatients taking warfarin. Ann Intern Med 1994; 120: 897-902.
17. Spandorfer J. The management of anticoagulation before and after procedures. Med Clin North Am 2001; 85: 1109-16.
18. Baglin TP, Keeling D M, Watson HG. Guidelines on oral anticoagulation: third edn 2005 update. Br J Haematol 2005; 132: 277-85.